Grupo Aeroportuario del Pacifico Reports in April 2024 a Passenger Traffic Decrease of 7.3% Compared to 2023
May 03, 2024 18:34 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, May 03, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger...
Grupo Aeroportuario del Pacifico Announces Results for the First Quarter of 2024
April 22, 2024 21:14 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, April 22, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the first...
Grupo Aeroportuario del Pacifico Reports in March 2024 a Passenger Traffic Decrease of 0.6% Compared to 2023
April 04, 2024 18:50 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, April 04, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger...
Crossbow Therapeutics Selects First Development Candidate from its Portfolio of Next-Generation T-cell Engagers Directed at Intracellular Cancer Targets
March 05, 2024 17:10 ET
|
Crossbow Therapeutics
Crossbow Therapeutics today announced the nomination of its first development candidate, CBX-250, a T-cell engager for the treatment of myeloid leukemia.
Grupo Aeroportuario del Pacifico Reports in February 2024 A Passenger Traffic Increase of 1.7% Compared to 2023
March 05, 2024 16:22 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, March 05, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger...
Grupo Aeroportuario del Pacifico Announces Results for the Fourth Quarter of 2023
February 26, 2024 19:27 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the fourth...
Grupo Aeroportuario del Pacifico Reports in January 2024 a Passenger Traffic Decrease of 0.6% Compared to 2023
February 06, 2024 19:20 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger...
Cybrexa Regains Rights to CBX-12
February 06, 2024 08:00 ET
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
Grupo Aeroportuario del Pacifico Reports in December 2023 a Passenger Traffic Increase of 2.2% Compared to 2022
January 05, 2024 16:09 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger...
Grupo Aeroportuario del Pacifico Reports in November 2023 a Passenger Traffic Increase of 0.7% Compared to 2022
December 05, 2023 19:33 ET
|
Grupo Aeroportuario del Pacífico, S.A.B. de C.V.
GUADALAJARA, Mexico, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger...